Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids

被引:22
|
作者
Mallory, S
Sommer, M
Arvin, AM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Immunol Microbiol, Stanford, CA 94305 USA
来源
关键词
D O I
10.1086/514277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contributions of the glycoproteins gI (ORF67) and gE (ORF68) to varicella-zoster virus (VZV) replication were investigated in deletion mutants made by using cosmids with VZV DNA derived from the Oka strain. These experiments demonstrated that gI was not required for VZV replication in vitro but gE appeared to be. Although VZV gI was not required, its deletion or mutation resulted in a significant decrease in infectious virus yields, and it disrupted syncytial formation and altered the conformation and distribution of gE in infected cells. Normal cell-to-cell spread and replication kinetics were restored when gI was expressed from a non-native locus in the VZV genome. The expression of intact gI, the ORF67 gene product, is required for efficient VZV replication.
引用
收藏
页码:S22 / S26
页数:5
相关论文
共 50 条
  • [41] ACTIVATION OF LYMPHOCYTES BY VARICELLA-ZOSTER VIRUS (VZV) - EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON LYMPHOCYTES CULTURED WITH VZV ANTIGEN
    ITO, M
    NAKANO, T
    KAMIYA, T
    KITAMURA, K
    KOMADA, Y
    IHARA, T
    KAMIYA, H
    SAKURAI, M
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01): : 158 - 161
  • [42] VARICELLA-ZOSTER VIRUS (VZV) OPEN READING FRAME-61 PROTEIN TRANSACTIVATES VZV GENE PROMOTERS AND ENHANCES THE INFECTIVITY OF VZV-DNA
    MORIUCHI, H
    MORIUCHI, M
    STRAUS, SE
    COHEN, JI
    JOURNAL OF VIROLOGY, 1993, 67 (07) : 4290 - 4295
  • [43] Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?
    Cinque, P
    Bossolasco, S
    Vago, L
    Fornara, C
    Lipari, S
    Racca, S
    Lazzarin, A
    Linde, A
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 634 - 639
  • [44] ABSENCE OF VARICELLA-ZOSTER VIRUS (VZV) GLYCOPROTEIN-V DOES NOT ALTER GROWTH OF VZV IN-VITRO OR SENSITIVITY TO HEPARIN
    COHEN, JI
    SEIDEL, KE
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 3087 - 3093
  • [45] The varicella-zoster virus (VZV) open-reading frame 29 protein acts as a modulator of a late VZV gene promoter
    Boucaud, D
    Yoshitake, H
    Hay, J
    Ruyechan, W
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 : S34 - S38
  • [46] REACTIVATION OF VARICELLA-ZOSTER VIRUS AFTER ABMT IS ASSOCIATED WITH SPECIFIC DEFICIENCY OF IGG TO VZV
    KELSEY, SM
    BERNARD, T
    SOLIMAN, A
    WITHERS, M
    WAINWRIGHT, A
    NEWLAND, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 11 - 11
  • [47] DETECTION OF VARICELLA-ZOSTER VIRUS (VZV) DNA IN CLINICAL-SAMPLES FROM PATIENTS WITH VZV BY THE POLYMERASE CHAIN-REACTION
    KIDO, S
    OZAKI, T
    ASADA, H
    HIGASHI, K
    KONDO, K
    HAYAKAWA, Y
    MORISHIMA, T
    TAKAHASHI, M
    YAMANISHI, K
    JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (01) : 76 - 79
  • [48] Amplification and sequencing of varicella-zoster virus (vzv) gene 4: Point mutation in a VZV strain causing chickenpox during pregnancy
    Chow, VTK
    Lim, KP
    ACTA VIROLOGICA, 1997, 41 (05) : 277 - 283
  • [49] INHIBITION OF VARICELLA-ZOSTER VIRUS (VZV) GLYCOPROTEIN EXPRESSION BY A HUMAN MONOCLONAL-ANTIBODY AGAINST VZV GLYCOPROTEIN-III
    ITO, M
    MIZUTANI, K
    KAMIYA, T
    IHARA, T
    KAMIYA, H
    SAKURAI, M
    SUGANO, T
    MATUMOTO, Y
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05): : 1256 - 1259
  • [50] Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation
    Nagel, Maria A.
    Khmeleva, Nelly
    Choe, Alexander
    Gutierrez, Jose
    Gilden, Don
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 339 (1-2) : 32 - 34